| Filed On | Filing |
|---|---|
| 25 Sep 2026 |
8-K/A: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
WILMINGTON, Del., September 24, 2026 — Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) today announced the appointments of former U.S. Senator Robert Torricelli and Dr. Brian J. Miller, M.D., ... |
| 06 Mar 2026 |
8-K/A: Regulation FD Disclosure
Clover Health (Nasdaq: CLOV) Fourth Quarter 2025 Supplemental Q&A March 6, 2026 In advance of our fourth quarter and full year 2025 earnings call, we once again invited shareholders to submit their questions on Clover Health and our outl... |
| 01 Apr 2021 | 8-K/A: Results of Operations and Financial Condition |
| 01 Apr 2021 | 8-K/A: Financial Statements and Exhibits |
Loading...
